Torrent Pharmaceuticals Ltd. It was founded in 1959 by U. N.

Mehta, initially operating as a small-scale pharmaceutical formulation unit. Over the years, the company expanded its operations and product portfolio, becoming one of the leading pharmaceutical companies in India. The company's headquarters is located in Bhat village, near Ahmedabad, Gujarat.

The modern facility houses state-of-the-art manufacturing units, research and development centers, quality control laboratories, and administrative offices. The headquarters also include an expansive warehouse and distribution network to cater to the company's domestic and international markets. Torrent Pharma offers a wide range of products and services in various therapeutic segments such as cardiology, gastroenterology, diabetology, psychiatry, pain management, and more.

The company focuses on the development, manufacturing, and marketing of both generic and branded pharmaceutical products. They have a robust pipeline of new products and invest heavily in research and development to bring innovative treatment options to patients. Operating on a global scale, Torrent Pharma has a strong presence in over 50 countries worldwide.

The company has set up wholly-owned subsidiaries in various countries, including the United States, United Kingdom, Germany, Brazil, and Russia, to strengthen its global footprint. Additionally, Torrent Pharma has formed strategic partnerships and joint ventures with international pharmaceutical companies to enhance its product offerings and market reach. In terms of market position, Torrent Pharma has achieved significant growth and has emerged as one of the top pharmaceutical companies in India.

It has a strong competitive position both domestically and globally, with a focus on quality, affordability, and accessibility of its products. The company's global sales have seen consistent growth, driven by its presence in key markets and strong customer relationships. Over the years, Torrent Pharma has witnessed several major events and achievements.

In 2017, the company acquired the branded business of Unichem Laboratories in India and Nepal, further expanding its product portfolio and market presence. In 2019, Torrent Pharma ranked among the top 100 pharmaceutical companies globally by revenues, underlining its strong performance in the industry. As of the latest updates, Torrent Pharma continues to invest in research and development, regulatory compliance, and international expansion to fuel its growth.

The company remains committed to providing high-quality and affordable healthcare solutions to patients worldwide while steadily gaining market share and strengthening its position in the pharmaceutical industry